NBW Capital LLC Sells 1,820 Shares of Steris PLC (NYSE:STE)

NBW Capital LLC lessened its stake in Steris PLC (NYSE:STE) by 5.0% in the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 34,407 shares of the medical equipment provider’s stock after selling 1,820 shares during the period. Steris comprises 1.5% of NBW Capital LLC’s portfolio, making the stock its 26th biggest holding. NBW Capital LLC’s holdings in Steris were worth $4,971,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in STE. Commerce Bank increased its position in Steris by 17.5% in the 2nd quarter. Commerce Bank now owns 2,394 shares of the medical equipment provider’s stock valued at $356,000 after acquiring an additional 357 shares during the period. Quantamental Technologies LLC acquired a new stake in shares of Steris during the second quarter worth $682,000. WINTON GROUP Ltd grew its holdings in Steris by 82.0% in the second quarter. WINTON GROUP Ltd now owns 10,479 shares of the medical equipment provider’s stock worth $1,560,000 after purchasing an additional 4,720 shares during the period. LPL Financial LLC grew its holdings in Steris by 22.6% in the second quarter. LPL Financial LLC now owns 14,778 shares of the medical equipment provider’s stock worth $2,202,000 after purchasing an additional 2,729 shares during the period. Finally, TimesSquare Capital Management LLC acquired a new stake in Steris in the second quarter worth $60,058,000. Institutional investors and hedge funds own 88.11% of the company’s stock.

Shares of Steris stock traded down $0.76 during trading hours on Thursday, reaching $144.73. The company’s stock had a trading volume of 6,331 shares, compared to its average volume of 414,478. Steris PLC has a one year low of $99.14 and a one year high of $156.66. The company has a market capitalization of $11.90 billion, a P/E ratio of 29.56 and a beta of 0.88. The stock’s fifty day simple moving average is $142.13 and its two-hundred day simple moving average is $142.88. The company has a debt-to-equity ratio of 0.40, a quick ratio of 1.87 and a current ratio of 2.41.

Steris (NYSE:STE) last released its quarterly earnings data on Monday, November 4th. The medical equipment provider reported $1.32 earnings per share for the quarter, beating analysts’ consensus estimates of $1.26 by $0.06. Steris had a net margin of 11.59% and a return on equity of 14.35%. The firm had revenue of $736.84 million for the quarter, compared to analyst estimates of $717.79 million. During the same period last year, the firm earned $1.10 earnings per share. The business’s quarterly revenue was up 8.5% compared to the same quarter last year. As a group, research analysts forecast that Steris PLC will post 5.58 earnings per share for the current year.

The company also recently declared a quarterly dividend, which will be paid on Friday, December 20th. Investors of record on Tuesday, November 26th will be given a dividend of $0.37 per share. This represents a $1.48 dividend on an annualized basis and a dividend yield of 1.02%. The ex-dividend date is Monday, November 25th. Steris’s payout ratio is currently 30.27%.

In related news, VP John Adam Zangerle sold 1,000 shares of the firm’s stock in a transaction dated Friday, October 4th. The shares were sold at an average price of $142.15, for a total transaction of $142,150.00. Also, VP Renato Tamaro sold 2,065 shares of the firm’s stock in a transaction dated Wednesday, August 14th. The shares were sold at an average price of $153.15, for a total transaction of $316,254.75. The disclosure for this sale can be found here. 2.36% of the stock is owned by company insiders.

Separately, ValuEngine cut shares of Steris from a “buy” rating to a “hold” rating in a report on Wednesday, October 2nd. One investment analyst has rated the stock with a hold rating and five have assigned a buy rating to the company. Steris presently has an average rating of “Buy” and a consensus target price of $148.20.

Steris Company Profile

STERIS plc provides infection prevention and other procedural products and services worldwide. The company operates in four segments: Healthcare Products, Healthcare Specialty Services, Life Sciences, and Applied Sterilization Technologies. The Healthcare Products segment offers cleaning chemistries and sterility assurance products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operations of a sterile processing department; and equipment used in the operating room, including surgical tables, lights, equipment management services, and connectivity solutions.

Featured Story: How to invest in a bear market

Want to see what other hedge funds are holding STE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Steris PLC (NYSE:STE).

Institutional Ownership by Quarter for Steris (NYSE:STE)

Receive News & Ratings for Steris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Steris and related companies with MarketBeat.com's FREE daily email newsletter.